Update from Alcobra on Recent FDA Communications
October 07, 2016 08:48 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Oct. 07, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
Alcobra Announces IND Clinical Hold Affecting the MDX Phase III MEASURE Study
September 28, 2016 20:01 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
Alcobra Announces Second Quarter 2016 Financial Results and Provides Corporate Update
August 30, 2016 07:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Aug. 30, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
Alcobra Ltd. to Release Second Quarter Financial Results and Host Corporate Update Conference Call & Webcast on Tuesday, August 30
August 15, 2016 08:00 ET
|
Alcobra Ltd.
Tel Aviv, Israel, Aug. 15, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Granted European Orphan Drug Designation for Metadoxine in Fragile X Syndrome
July 19, 2016 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, July 19, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
July 05, 2016 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, July 05, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
Alcobra Ltd. to Participate in Upcoming Investment Conferences
June 01, 2016 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, June 01, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
Alcobra Announces First Quarter 2016 Financial Results and Provides Corporate Update
May 16, 2016 08:00 ET
|
Alcobra Ltd.
Conference Call & Webcast May 16th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, May 16, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical...
Alcobra Ltd. to Release First Quarter Financial Results and Host Corporate Update Conference Call & Webcast on May 16
May 04, 2016 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, May 04, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at Upcoming Investment Conferences
March 01, 2016 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, March 01, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...